The Cigna Group (NYSE:CI) Shares Purchased by Eads & Heald Wealth Management

Eads & Heald Wealth Management boosted its stake in shares of The Cigna Group (NYSE:CI) by 2.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,167 shares of the health services provider’s stock after purchasing an additional 44 shares during the quarter. Eads & Heald Wealth Management’s holdings in The Cigna Group were worth $649,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Avestar Capital LLC increased its holdings in The Cigna Group by 0.8% during the 3rd quarter. Avestar Capital LLC now owns 4,585 shares of the health services provider’s stock worth $1,312,000 after purchasing an additional 35 shares during the period. Relyea Zuckerberg Hanson LLC increased its holdings in The Cigna Group by 3.2% during the 4th quarter. Relyea Zuckerberg Hanson LLC now owns 1,113 shares of the health services provider’s stock worth $333,000 after purchasing an additional 35 shares during the period. Strategic Blueprint LLC increased its holdings in The Cigna Group by 4.8% during the 3rd quarter. Strategic Blueprint LLC now owns 784 shares of the health services provider’s stock worth $224,000 after purchasing an additional 36 shares during the period. Wambolt & Associates LLC increased its holdings in shares of The Cigna Group by 1.4% in the 2nd quarter. Wambolt & Associates LLC now owns 2,536 shares of the health services provider’s stock valued at $712,000 after acquiring an additional 36 shares during the last quarter. Finally, Linscomb & Williams Inc. increased its holdings in shares of The Cigna Group by 0.3% in the 4th quarter. Linscomb & Williams Inc. now owns 10,877 shares of the health services provider’s stock valued at $3,604,000 after acquiring an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of recent analyst reports. Sanford C. Bernstein upgraded The Cigna Group from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $330.00 to $372.00 in a report on Thursday, January 4th. Oppenheimer reiterated an “outperform” rating and issued a $360.00 price objective on shares of The Cigna Group in a report on Wednesday, January 17th. Barclays assumed coverage on The Cigna Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $393.00 price target on the stock. Mizuho raised their price target on The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a research note on Monday, February 5th. Finally, Deutsche Bank Aktiengesellschaft upgraded The Cigna Group from a “hold” rating to a “buy” rating and raised their price target for the stock from $355.00 to $370.00 in a research note on Thursday, February 1st. Two investment analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, The Cigna Group presently has an average rating of “Buy” and a consensus price target of $362.14.

Insider Activity at The Cigna Group

In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the sale, the senior vice president now directly owns 2,102 shares in the company, valued at $694,668.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the sale, the senior vice president now directly owns 2,102 shares in the company, valued at $694,668.96. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO David Cordani sold 38,065 shares of the business’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $335.22, for a total value of $12,760,149.30. Following the completion of the transaction, the chief executive officer now directly owns 329,321 shares of the company’s stock, valued at $110,394,985.62. The disclosure for this sale can be found here. Insiders have sold a total of 114,144 shares of company stock worth $39,296,330 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

The Cigna Group Stock Performance

The Cigna Group stock traded down $0.28 during mid-day trading on Tuesday, reaching $348.62. 395,982 shares of the company were exchanged, compared to its average volume of 1,588,303. The Cigna Group has a twelve month low of $240.50 and a twelve month high of $365.71. The firm’s 50-day simple moving average is $347.04 and its two-hundred day simple moving average is $314.14. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.67 and a current ratio of 0.67. The firm has a market cap of $101.92 billion, a PE ratio of 20.06, a price-to-earnings-growth ratio of 1.07 and a beta of 0.56.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Friday, February 2nd. The health services provider reported $6.79 earnings per share for the quarter, topping analysts’ consensus estimates of $6.54 by $0.25. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The company had revenue of $51.15 billion during the quarter, compared to analysts’ expectations of $48.91 billion. During the same period last year, the firm earned $4.96 EPS. The firm’s revenue for the quarter was up 11.8% on a year-over-year basis. Equities analysts predict that The Cigna Group will post 28.36 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 21st. Investors of record on Wednesday, March 6th were paid a $1.40 dividend. The ex-dividend date was Tuesday, March 5th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.23. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.61%. The Cigna Group’s payout ratio is 32.20%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.